Investigation Overview
July 14, 2014 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares CTI BioPharma Corp (NASDAQ:CTIC) shares was announced over potential breaches of fiduciary duties by certain officers and directors at CTI BioPharma, formerly Cell Therapeutics. The investigation by a law firm concerns whether certain CTI BioPharma officers and directors brea...
You must register (for free) or login to view the entire investigation.